The rs738409 (I148M) variant of the PNPLA3 gene and cirrhosis: A meta-analysis

Journal of Lipid Research

Volumn 56, Issue 1, 2015, Pages 167-175

  Shen, Jian Hua ^a   Li, Yi Ling ^a   Li, Dan ^a   Wang, Ning Ning ^a   Jing, Lei ^a   Huang, Yu Hong ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Cirrhosis; Patatin like phospholipase domain containing 3 gene; Polymorphism

Indexed keywords

ARTICLE; COCHRANE LIBRARY; DNA POLYMORPHISM; GENE; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HUMAN; LIVER CIRRHOSIS; LIVER DISEASE; MEDLINE; META ANALYSIS; NUCLEIC ACID BASE SUBSTITUTION; PATATIN LIKE PHOSPHOLIPASE DOMAIN CONTAINING 3 GENE; PROSPECTIVE STUDY; PUBLISHING; RETROSPECTIVE STUDY; RISK ASSESSMENT; ALLELE; ENZYMOLOGY; GENETICS; SINGLE NUCLEOTIDE POLYMORPHISM;

ADIPONUTRIN, HUMAN; MEMBRANE PROTEIN; TRIACYLGLYCEROL LIPASE;

ALLELES; GENOTYPE; HUMANS; LIPASE; LIVER CIRRHOSIS; MEMBRANE PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84920682364     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M048777     Document Type: Article

References (49)

1. National Institutes of Health. Surveillance report #93: liver cirrhosis mortality in the United States, 1970-2009. Accessed September 10, 2013, at http://pubs.niaaa.nih.gov/publications/Surveillance93/Cirr09.htm.
2. Blachier, M., H. Leleu, M. Peck-Radosavljevic, D. C. Valla, and F. Roudot-Thoraval. 2013. The burden of liver disease in Europe: a review of available epidemiological data. J. Hepatol. 58:593-608.
3. Teli, M. R., C. P. Day, A. D. Burt, M. K. Bennett, and O. F. James. 1995. Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver. Lancet. 346:987-990.
4. Becker, U., A. Deis, T. I. Sorensen, M. Gronbaek, K. Borch-Johnsen, C. F. Muller, P. Schnohr, and G. Jensen. 1996. Prediction of risk of liver disease by alcohol intake, sex, and age: a prospective population study. Hepatology. 23:1025-1029.
5. Naveau, S., V. Giraud, E. Borotto, A. Aubert, F. Capron, and J. C. Chaput. 1997. Excess weight risk factor for alcoholic liver disease. Hepatology. 25:108-111.
6. Raynard, B., A. Balian, D. Fallik, F. Capron, P. Bedossa, J. C. Chaput, and S. Naveau. 2002. Risk factors of fibrosis in alcohol-induced liver disease. Hepatology. 35:635-638.
7. Mathurin, P., F. Beuzin, A. Louvet, N. Carrie-Ganne, A. Balian, J. C. Trinchet, D. Dalsoglio, S. Prevot, and S. Naveau. 2007. Fibrosis progression occurs in a subgroup of heavy drinkers with typical histological features. Aliment. Pharmacol. Ther. 25:1047-1054.
8. Nishiguchi, S., T. Kuroki, T. Yabusako, S. Seki, K. Kobayashi, T. Monna, S. Otani, M. Sakurai, T. Shikata, and S. Yamamoto. 1991. Detection of hepatitis C virus antibodies and hepatitis C virus RNA in patients with alcoholic liver disease. Hepatology. 14:985-989.
9. Mann, R. E., R. G. Smart, and R. Govoni. 2003. The epidemiology of alcoholic liver disease. Alcohol Res. Health. 27:209-219.
10. Stickel, F., and C. H. Osterreicher. 2006. The role of genetic polymorphisms in alcoholic liver disease. Alcohol Alcohol. 41:209-224.
11. Romeo, S., J. Kozlitina, C. Xing, A. Pertsemlidis, D. Cox, L. A. Pennacchio, E. Boerwinkle, J. C. Cohen, and H. H. Hobbs. 2008. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat. Genet. 40:1461-1465.
12. Yuan, X., D. Waterworth, J. R. Perry, N. Lim, K. Song, J. C. Chambers, W. Zhang, P. Vollenweider, H. Stirnadel, T. Johnson, et al. 2008. Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes. Am. J. Hum. Genet. 83:520-528.
13. Dongiovanni, P., B. Donati, R. Fares, R. Lombardi, R. M. Mancina, S. Romeo, and L. Valenti. 2013. PNPLA3 I148M polymorphism and progressive liver disease. World J. Gastroenterol. 19:6969-6978.
14. Wilson, P. A., S. D. Gardner, N. M. Lambie, S. A. Commans, and D. J. Crowther. 2006. Characterization of the human patatin-like phospholipase family. J. Lipid Res. 47:1940-1949.
15. Huang, Y., J. C. Cohen, and H. H. Hobbs. 2011. Expression and characterization of a PNPLA3 protein isoform (I148M) associated with nonalcoholic fatty liver disease. J. Biol. Chem. 286:37085-37093.
16. Kantartzis, K., A. Peter, F. Machicao, J. Machann, S. Wagner, I. Konigsrainer, A. Konigsrainer, F. Schick, A. Fritsche, H. U. Haring, et al. 2009. Dissociation between fatty liver and insulin resistance in humans carrying a variant of the patatin-like phospholipase 3 gene. Diabetes. 58:2616-2623.
17. Kotronen, A., L. E. Johansson, L. M. Johansson, C. Roos, J. Westerbacka, A. Hamsten, R. Bergholm, P. Arkkila, J. Arola, T. Kiviluoto, et al. 2009. A common variant in PNPLA3, which encodes adiponutrin, is associated with liver fat content in humans. Diabetologia. 52:1056-1060.
18. Romeo, S., F. Sentinelli, S. Dash, G. S. Yeo, D. B. Savage, F. Leonetti, D. Capoccia, M. Incani, C. Maglio, M. Iacovino, et al. 2010. Morbid obesity exposes the association between PNPLA3 I148M (rs738409) and indices of hepatic injury in individuals of European descent. Int. J. Obes. (Lond.). 34:190-194.
19. Sookoian, S., G. O. Castano, A. L. Burgueno, T. F. Gianotti, M. S. Rosselli, and C. J. Pirola. 2009. A nonsynonymous gene variant in the adiponutrin gene is associated with nonalcoholic fatty liver disease severity. J. Lipid Res. 50:2111-2116.
20. Krawczyk, M., F. Grunhage, V. Zimmer, and F. Lammert. 2011. Variant adiponutrin (PNPLA3) represents a common fibrosis risk gene: non-invasive elastography-based study in chronic liver disease. J. Hepatol. 55:299-306.
21. Trépo, E., T. Gustot, D. Degré, A. Lemmers, L. Verset, P. Demetter, R. Ouziel, E. Quertinmont, V. Vercruysse, L. Amininejad, et al. 2011. Common polymorphism in the PNPLA3/adiponutrin gene confers higher risk of cirrhosis and liver damage in alcoholic liver disease. J. Hepatol. 55:906-912.
22. Tian, C., R. P. Stokowski, D. Kershenobich, D. G. Ballinger, and D. A. Hinds. 2010. Variant in PNPLA3 is associated with alcoholic liver disease. Nat. Genet. 42:21-23.
23. Nischalke, H. D., C. Berger, C. Luda, T. Berg, T. Muller, F. Grunhage, F. Lammert, M. Coenen, B. Kramer, C. Korner, et al. 2011. The PNPLA3 rs738409 148M/M genotype is a risk factor for liver cancer in alcoholic cirrhosis but shows no or weak association in hepatitis C cirrhosis. PLoS ONE. 6:e27087.
24. Stickel, F., S. Buch, K. Lau, H. Meyer zu Schwabedissen, T. Berg, M. Ridinger, M. Rietschel, C. Schafmayer, F. Braun, H. Hinrichsen, et al. 2011. Genetic variation in the PNPLA3 gene is associated with alcoholic liver injury in Caucasians. Hepatology. 53:86-95.
25. Falleti, E., C. Fabris, S. Cmet, A. Cussigh, D. Bitetto, E. Fontanini, E. Fornasiere, S. Bignulin, E. Fumolo, E. Bignulin, et al. 2011. PNPLA3 rs738409C/G polymorphism in cirrhosis: relationship with the aetiology of liver disease and hepatocellular carcinoma occurrence. Liver Int. 31:1137-1143.
26. Valenti, L., and V. Nobili. 2011. PNPLA3 I148M polymorphism and liver damage in obese children. J. Pediatr. 159:876.
27. Valenti, L., M. Rumi, E. Galmozzi, A. Aghemo, B. Del Menico, S. De Nicola, P. Dongiovanni, M. Maggioni, A. L. Fracanzani, R. Rametta, et al. 2011. Patatin-like phospholipase domain-containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C. Hepatology. 53:791-799.
28. Sookoian, S., and C. J. Pirola. 2011. Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease. Hepatology. 53:1883-1894.
29. Valenti, L., A. Al-Serri, A. K. Daly, E. Galmozzi, R. Rametta, P. Dongiovanni, V. Nobili, E. Mozzi, G. Roviaro, E. Vanni, et al. 2010. Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with non-alcoholic fatty liver disease. Hepatology. 51:1209-1217.
30. Rotman, Y., C. Koh, J. M. Zmuda, D. E. Kleiner, and T. J. Liang. 2010. The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease. Hepatology. 52:894-903.
31. Speliotes, E. K., J. L. Butler, C. D. Palmer, B. F. Voight, and J. N. Hirschhorn. 2010. PNPLA3 variants specifically confer increased risk for histologic nonalcoholic fatty liver disease but not metabolic disease. Hepatology. 52:904-912.
32. Valenti, L., A. Alisi, E. Galmozzi, A. Bartuli, B. Del Menico, A. Alterio, P. Dongiovanni, S. Fargion, and V. Nobili. 2010. I148M patatin-like phospholipase domain-containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease. Hepatology. 52:1274-1280.
33. Valenti, L., P. Maggioni, A. Piperno, R. Rametta, S. Pelucchi, R. Mariani, P. Dongiovanni, A. L. Fracanzani, and S. Fargion. 2012. Patatin-like phospholipase domain containing-3 gene I148M polymorphism, steatosis, and liver damage in hereditary hemochromatosis. World J. Gastroenterol. 18:2813-2820.
34. Moher, D., A. Liberati, J. Tetzlaff, and D. G. Altman. 2010. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int. J. Surg. 8:336-341.
35. Wells, G. A., B. Shea, D. O'Connell, J. Peterson, V. Welch, M. Losos, and P. Tugwell. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Accessed September 10, 2013, at http://www.medicine.mcgill.ca/rtamblyn/Readings/The%20Newcastle%20-%20Scale%20for%20assessing%20the%20quality%20of%20nonrandomised%20studies%20in%20meta-analyses.pdf.
36. DerSimonian, R., and N. Laird. 1986. Meta-analysis in clinical trials. Control. Clin. Trials. 7:177-188.
37. Dutta, A. K. 2013. Genetic factors affecting susceptibility to alcoholic liver disease in an Indian population. Ann. Hepatol. 12:901-907.
38. Lazo, M., and J. M. Clark. 2008. The epidemiology of nonalcoholic fatty liver disease: a global perspective. Semin. Liver Dis. 28:339-350.
39. Lin, Y. C., P. F. Chang, M. H. Chang, and Y. H. Ni. 2014. Genetic variants in GCKR and PNPLA3 confer susceptibility to nonalcoholic fatty liver disease in obese individuals. Am. J. Clin. Nutr. 99:869-874.
40. Tan, H. L., S. M. Zain, R. Mohamed, S. Rampal, K. F. Chin, R. C. Basu, P. L. Cheah, S. Mahadeva, and Z. Mohamed. 2014. Association of glucokinase regulatory gene polymorphisms with risk and severity of non-alcoholic fatty liver disease: an interaction study with adiponutrin gene. J. Gastroenterol. 49:1056-1064.
41. Hassan, M. M., A. Kaseb, C. J. Etzel, H. El-Serag, M. R. Spitz, P. Chang, K. S. Hale, M. Liu, A. Rashid, M. Shama, et al. 2013. Genetic variation in the PNPLA3 gene and hepatocellular carcinoma in USA: risk and prognosis prediction. Mol. Carcinog. 52 (Suppl. 1):E139-E147.
42. Kitamoto, T., A. Kitamoto, M. Yoneda, H. Hyogo, H. Ochi, T. Nakamura, H. Teranishi, S. Mizusawa, T. Ueno, K. Chayama, et al. 2013. Genome-wide scan revealed that polymorphisms in the PNPLA3, SAMM50, and PARVB genes are associated with development and progression of nonalcoholic fatty liver disease in Japan. Hum. Genet. 132:783-792.
43. Peng, X. E., Y. L. Wu, S. W. Lin, Q. Q. Lu, Z. J. Hu, and X. Lin. 2012. Genetic variants in PNPLA3 and risk of non-alcoholic fatty liver disease in a Han Chinese population. PLoS ONE. 7:e50256.
44. Hotta, K., M. Yoneda, H. Hyogo, H. Ochi, S. Mizusawa, T. Ueno, K. Chayama, A. Nakajima, K. Nakao, and A. Sekine. 2010. Association of the rs738409 polymorphism in PNPLA3 with liver damage and the development of nonalcoholic fatty liver disease. BMC Med. Genet. 11:172.
45. Stickel, F., and J. Hampe. 2012. Genetic determinants of alcoholic liver disease. Gut. 61:150-159.
46. Trépo, E., P. Nahon, G. Bontempi, L. Valenti, E. Falleti, H. D. Nischalke, S. Hamza, S. G. Corradini, M. A. Burza, E. Guyot, et al. 2014. Association between the PNPLA3 (rs738409 C>G) variant and hepatocellular carcinoma: evidence from a meta-analysis of individual participant data. Hepatology. 59:2170-2177.
47. Ruhanen, H., J. Perttila, M. Holtta-Vuori, Y. Zhou, H. Yki-Jarvinen, E. Ikonen, R. Kakela, and V. M. Olkkonen. 2014. PNPLA3 mediates hepatocyte triacylglycerol remodeling. J. Lipid Res. 55:739-746.
48. Pingitore, P., C. Pirazzi, R. M. Mancina, B. M. Motta, C. Indiveri, A. Pujia, T. Montalcini, K. Hedfalk, and S. Romeo. 2014. Recombinant PNPLA3 protein shows triglyceride hydrolase activity and its I148M mutation results in loss of function. Biochim. Biophys. Acta. 1841:574-580.
49. Flores, Y. N., H. F. Yee, Jr., M. Leng, J. J. Escarce, R. Bastani, J. Salmeron, and L. S. Morales. 2008. Risk factors for chronic liver disease in blacks, Mexican Americans, and whites in the United States: results from NHANES IV, 1999-2004. Am. J. Gastroenterol. 103:2231-2238.